Trials / Completed
CompletedNCT04002856
Aesthetic Performance of "Profhilo®" Injective Intradermal Treatment for the Neck
Aesthetic Performance and Tolerance Evaluation of "Profhilo®" Injective Intradermal Treatment for the Skin Roughness and Laxity of the Neck
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- Derming SRL · Academic / Other
- Sex
- Female
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study is to investigate the aesthetic performance of the Hyaluronic acid (HA)-based dermal filler Profhilo® injected by a novel bio aesthetic point technique ("BAP" techinique ) in woman aged 40-65 years with skin flaccidity and roughness of the neck.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Profhilo® | Profhilo® (IBSA Farmaceutici Italia S.r.l.) is a resorbable medical device 2.25 ml non-pyrogenic pre-filled syringe, containing 2 ml of 3.2% hyaluronic acid for intradermal use (32 mg H-HA + 32 mg L-HA dissolved in 2 ml of saline buffered sodium chloride |
Timeline
- Start date
- 2019-02-18
- Primary completion
- 2019-06-21
- Completion
- 2019-06-21
- First posted
- 2019-07-01
- Last updated
- 2019-07-18
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04002856. Inclusion in this directory is not an endorsement.